Evidence map›Paper›PMID 27029948›Full record

ArticleStem cell research & therapy2016

Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics.

C C West, W R Hardy, I R Murray, A W James, M Corselli, S Pang, C Black, S E Lobo, K Sukhija, P Liang and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Stem cell research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

C C WestBritish Heart Foundation Centre for Vascular Regeneration & Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
W R HardyOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
I R MurrayBritish Heart Foundation Centre for Vascular Regeneration & Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
A W JamesOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
M CorselliOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
S PangOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
C BlackOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
S E LoboOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
K SukhijaOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
P LiangOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
V LagishettyOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
D C HayBritish Heart Foundation Centre for Vascular Regeneration & Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
K L MarchIndiana Center for Vascular Biology and Medicine, Krannert Institute of Cardiology, and Vascular and Cardiac Center for Adult Stem Cell Research, Indiana University, Bloomington, IN, USA.
K TingOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
C SooOrthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA.
B PéaultBritish Heart Foundation Centre for Vascular Regeneration & Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK. bpeault@mednet.ucla.edu.
Orthopaedic Hospital · USBD Biosciences (United States) · USBritish Heart Foundation · GBIndiana University Bloomington · USKaweah Delta Health Care District · USMedical Research Council · GBSt John's Hospital · GBUniversidade de São Paulo · BRUniversity of California, Los Angeles · US

Funding

Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial DiseaseUM1HL113457 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI MURPHY, MICHAEL PATRICK · 2012 to 2018
$3.0M
Training in Vascular Biology and MedicineT32HL079995 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARCH, KEITH LEONARD · 2005 to 2014
$2.2M
British Heart Foundation R42775Chief Scientist Office CAF/11/13Medical Research Council G1000816Medical Research Council MR/K017047/1Medical Research Council MR/K026666/1Medical Research Council MR/L012766/1Medical Research Council MR/L022974/1NHLBI NIH HHS 5T32HL079995-10NHLBI NIH HHS T32 HL079995NHLBI NIH HHS UM1 5UM1HL113457-04NHLBI NIH HHS UM1 HL113457Wellcome Trust 097483
6 · The paper itself

Abstract

backgroundAdipose tissue is an attractive source of mesenchymal stem cells (MSC) as it is largely dispensable and readily accessible through minimally invasive procedures such as liposuction. Until recently MSC could only be isolated in a process involving ex-vivo culture and their in-vivo identity, location and frequency remained elusive. We have documented that pericytes (CD45-, CD146+, and CD34-) and adventitial cells (CD45-, CD146-, CD34+) (collectively termed perivascular stem cells or PSC) represent native ancestors of the MSC, and can be prospectively purified using fluorescence activated cell sorting (FACS). In this study we describe an optimized protocol that aims to deliver pure, viable and consistent yields of PSC from adipose tissue. We analysed the frequency of PSC within adipose tissue, and the effect of patient and procedure based variables on this yield.

methodsWithin this twin centre study we analysed the adipose tissue of n = 131 donors using flow cytometry to determine the frequency of PSC and correlate this with demographic and processing data such as age, sex, BMI and cold storage time of the tissue.

resultsThe mean number of stromal vascular fraction (SVF) cells from 100 ml of lipoaspirate was 34.4 million. Within the SVF, mean cell viability was 83 %, with 31.6 % of cells being haematopoietic (CD45+). Adventitial cells and pericytes represented 33.0 % and 8 % of SVF cells respectively. Therefore, a 200 ml lipoaspirate would theoretically yield 23.2 million viable prospectively purified PSC - sufficient for many reconstructive and regenerative applications. Minimal changes were observed in respect to age, sex and BMI suggesting universal potential application.

conclusionsAdipose tissue contains two anatomically and phenotypically discreet populations of MSC precursors - adventitial cells and pericytes - together referred to as perivascular stem cells (PSC). More than 9 million PSC per 100 ml of lipoaspirate can be rapidly purified to homogeneity using flow cytometry in clinically relevant numbers potentially circumventing the need for purification and expansion by culture prior to clinical use. The number and viability of PSC are minimally affected by patient age, sex, BMI or the storage time of the tissue, but the quality and consistency of yield can be significantly influenced by procedure based variables.

Indexed as

AdultAntigens, CDCells, CulturedCell SeparationDemographyFemaleFlow CytometryHumansMaleMesenchymal Stem CellsMiddle AgedPericytesProspective StudiesSubcutaneous FatTissue PreservationYoung AdultAntigens, CDAdipose-derived stem cellAdipose tissueCell sortingFlow cytometryMesenchymal stem cellsPericyteTunica adventitia

Identifiers

PMID27029948
PMCPMC4815276
OpenAlexW2322623562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.